Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Blood Advances
|
July 11, 2022
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
Nazila Shafagati, Min J Koh, Leora Boussi, et al.
Genes, Chromosomes & Cancer
|
August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia
Ozgur Can Eren, Robert Stuver, Ting Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort
Rachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Haematologica
|
November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas
Kai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin
Shin Yeu Ong, Lu Chen, Jomel Meeko Manzano, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood Advances
|
January 13, 2022
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
Min Jung Koh, Mwanasha H Merrill, Min Ji Koh, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Blood Advances
|
July 11, 2022
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
Nazila Shafagati, Min J Koh, Leora Boussi, et al.
Genes, Chromosomes & Cancer
|
August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia
Ozgur Can Eren, Robert Stuver, Ting Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort
Rachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Haematologica
|
November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas
Kai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin
Shin Yeu Ong, Lu Chen, Jomel Meeko Manzano, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood Advances
|
January 13, 2022
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
Min Jung Koh, Mwanasha H Merrill, Min Ji Koh, et al.
Page
of 3